(Q30477604)

17 October 2017

1 reference

8 February 2021

Advances in the field of nanooncology (English)

1 reference

medical laboratory science

17 October 2017

1 reference

10 November 2020

1 reference

8 February 2021

1 reference

PubMed publication ID

21144040

nanotechnology

1 reference

PubMed publication ID

21144040

author name string

K K Jain

series ordinal

1

1 reference

17 October 2017

language of work or name

English

0 references

publication date

13 December 2010

4 references

17 October 2017

3 April 2019

10 November 2020

8 February 2021

4 references

17 October 2017

3 April 2019

10 November 2020

8 February 2021

8

1 reference

17 October 2017

83

1 reference

Creative Commons Attribution

17 October 2017

3 references

3 April 2019

10 November 2020

8 February 2021

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Image-guided breast tumor therapy using a small interfering RNA nanodrug

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Real-time optical imaging using quantum dot and related nanocrystals

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Targeting of drugs and nanoparticles to tumors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Passive and active drug targeting: drug delivery to tumors as an example

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Dendrimer-based nanoparticles for cancer therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Matrix-insensitive protein assays push the limits of biosensors in medicine.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

MS-qFRET: a quantum dot-based method for analysis of DNA methylation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Poly (amino acid) micelle nanocarriers in preclinical and clinical studies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Recent advances in nanooncology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Applications of nanobiotechnology in clinical diagnostics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Hyperthermic effects of gold nanorods on tumor cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Antibiological barrier nanovector technology for cancer applications.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Programmed drug delivery: nanosystems for tumor targeting

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Nanotechnology applications in cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Use of magnetic nanoparticle heating in the treatment of breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Role of nanobiotechnology in developing personalized medicine for cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3018446

Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy.

20 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-83

Formulating paclitaxel in nanoparticles alters its disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-83

Paclitaxel-Functionalized Gold Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-83

Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-83

Nanotechnology-based drug delivery for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-83

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-83

Biocompatible heterostructured nanoparticles for multimodal biological detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-83

Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-8-83

HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21144040

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nanoparticle enhanced thermal therapies

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21144040

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1741-7015-8-83

1 reference

Dimensions Publication ID

17 October 2017

0 references

1 reference

17 October 2017

PubMed publication ID

21144040

1 reference